Skip to main content
OpenTrials
Completed

NCT Number: NCT05897697

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

The preferences of pregnant women for postpartum thromboprophylaxis are largely unknown. The aims of this transversal study are to elicit the preferences of pregnant/postpartum women about postpartum thromboprophylaxis in semi-structured interviews, and to estimate the utility of the relevant health states (pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, subcutaneous injections). In this second aim, the investigators will also compare the effect of 2 different techniques to estimate utilities (standard gamble vs. time trade-off), using a randomization of these techniques.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Venous Thromboembolism Cardiovascular Diseases Embolism and Thrombosis Pregnancy Related Thromboembolism Vascular Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Justine Hugon-Rodin, Paris, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • women
  • ongoing pregnancy or within 7 days of delivery
  • fluency in French or English

Exclusion criteria

  • fetal or neonatal death

Treatment and study plan

interview

Other

Structured interview

Primary outcomes

  1. Preference for postpartum thromboprophylaxis

    Time frame: 90 days of delivery

    Risk of postpartum venous thromboembolism at which thromboprophylaxis is preferred

  2. Quality-of-life of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections

    Time frame: 90 days of delivery

    Measurements of utilities of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections, by standard gamble and time trade-off methods

Sponsors and collaborators

Lead sponsor

Marc Blondon

Other

Registry information

Acronym: PREFER-PP

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jun 9, 2023
Registry last updated
Jun 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.